Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07517770 · ClinicalTrials.gov registry record · NA
Effectiveness of Artificial-Intelligence (AI) Bolus Priming Added to an Existing Fully Automated Control Algorithm (AIDANET)
A NA study, sponsored by Sue Brown.
- Not yet
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07517770: Clinical Trial NA study, sponsored by Sue Brown.
NCT07517770 is a NA study that has not yet begun recruiting, run by Sue Brown. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07517770, a NA study, has not yet begun recruiting, sponsored by Sue Brown.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Bolus Priming (BP) based on Artificial Intelligence (AI) learning of meal patterns, added to our established Automated insulin delivery as Adaptive Network (AIDANET) algorithm and running on iPhone Diabetes Assistant (iDiAs) phone wirelessly connected to Tandem Mobi insulin pump and Dexcom Continuous Glucose Monitor (CGM).
Primary Outcome
The last two weeks of the 4-week AIDANET AI session will be used for analysis, comparing standard Ambulatory Glucose Profile metrics across AIDANET vs AIDANET AI, with primary outcome TIR (70-180 mg/dL) during the day.
Interventions
- DEVICE Hybrid Closed Loop (HCL) x 2 weeks
- DEVICE AIDANET x 2 weeks
- DEVICE AIDANET AI x 4 weeks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
What is known before NCT07517770 opens enrollment
NCT07517770 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Hybrid Closed Loop (HCL) x 2 weeks is the first listed.
NCT07517770 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07517770 about?
NCT07517770 is a clinical study titled "Effectiveness of Artificial-Intelligence (AI) Bolus Priming Added to an Existing Fully Automated Control Algorithm (AIDANET)". Bolus Priming (BP) based on Artificial Intelligence (AI) learning of meal patterns, added to our established Automated insulin delivery as Adaptive Network (AIDANET) algorithm and running on iPhone Diabetes Assistant (iDiAs) phone wirelessly connected to Tandem Mobi insulin pump and Dexcom Continuou...
What is the current status of trial NCT07517770?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-05-01. Estimated completion is 2027-04-30.
What interventions are being tested in trial NCT07517770?
The interventions under investigation include: Hybrid Closed Loop (HCL) x 2 weeks (DEVICE), AIDANET x 2 weeks (DEVICE), AIDANET AI x 4 weeks (DEVICE).
Who is sponsoring clinical trial NCT07517770?
This trial is sponsored by Sue Brown, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07517770's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI